December 31, 2025 · Form 4 insider transaction
Burnett Patrick sold 1,156 shares of Arcutis Biotherapeutics, Inc. at $29.39 per share, a transaction worth $34.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units, granted on August 3, 2020.; The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $29.0829 to $29.57, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.